Highvista Strategies LLC / RLAY
Highvista Strategies LLC’s Relay Therapeutics Inc Position
Does Highvista Strategies LLC own Relay Therapeutics Inc (RLAY)? Yes — 421.9K shares worth $4M (+1.16% of its 13F portfolio) as of Q1 2026, down from 545.1K shares the prior filed quarter.
Position Value
$4M
Q1 2026
Shares
421.9K
% of Portfolio
+1.16%
Quarters Held
15
currently held
Position History RLAY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 421.9K | $4M | +1.16% |
| Q4 2025 | 545.1K | $5M | +1.19% |
| Q3 2025 | 240.5K | $1M | +0.31% |
| Q2 2025 | 149.7K | $517,965 | +0.19% |
| Q2 2023 | 32.2K | $404,394 | +0.19% |
| Q1 2023 | 129.2K | $2M | +1.73% |
| Q4 2022 | 176.5K | $3M | +1.57% |
| Q3 2022 | 167.4K | $4M | +2.14% |
| Q2 2022 | 113.3K | $2M | +1.15% |
| Q1 2022 | 68.6K | $2M | +1.31% |
| Q4 2021 | 46.0K | $1M | +1.12% |
| Q3 2021 | 37.7K | $1M | +0.79% |
| Q2 2021 | 23.3K | $851,000 | +0.60% |
| Q1 2021 | 16.9K | $583,000 | +0.43% |
| Q4 2020 | 15.0K | $622,000 | +0.40% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Highvista Strategies LLC’s full portfolio or all institutional holders of RLAY.